Variant report
Variant | nsv979351 |
---|---|
Chromosome Location | chr2:188512645-188518146 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:2)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:2 , 50 per page) page:
1
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs181748903 | chr2:188512666-188512667 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs12469574 | chr2:188512774-188512775 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
3 | rs186262873 | chr2:188512788-188512789 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs554209818 | chr2:188512836-188512837 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs576213100 | chr2:188512842-188512843 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs543480394 | chr2:188512880-188512881 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs572442117 | chr2:188512919-188512920 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs561942299 | chr2:188512928-188512929 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs74836890 | chr2:188512929-188512930 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs562001417 | chr2:188512956-188512957 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs202054065 | chr2:188512986-188512987 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs529104877 | chr2:188512988-188512989 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs6710551 | chr2:188512989-188512990 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
14 | rs537429438 | chr2:188513024-188513025 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs190483280 | chr2:188513041-188513042 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs78383601 | chr2:188513042-188513043 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs17708110 | chr2:188513073-188513074 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs533940267 | chr2:188513094-188513095 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs533222987 | chr2:188513098-188513099 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs112522309 | chr2:188513101-188513102 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs551457089 | chr2:188513106-188513107 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs138707657 | chr2:188513166-188513167 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs55682494 | chr2:188513279-188513280 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
24 | rs376120029 | chr2:188513327-188513328 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs567942430 | chr2:188513329-188513330 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs547622718 | chr2:188513337-188513338 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs115063418 | chr2:188513360-188513361 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs11886510 | chr2:188513399-188513400 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
29 | rs571702497 | chr2:188513411-188513412 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs13389183 | chr2:188513414-188513415 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs554272943 | chr2:188513415-188513416 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs186266346 | chr2:188513455-188513456 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs116326428 | chr2:188513511-188513512 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs555421395 | chr2:188513562-188513563 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs139487854 | chr2:188513578-188513579 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs544140283 | chr2:188513583-188513584 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs149536479 | chr2:188513627-188513628 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs577389824 | chr2:188513637-188513638 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs370270805 | chr2:188513686-188513687 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs567359274 | chr2:188513694-188513695 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs371239201 | chr2:188513696-188513697 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs544720986 | chr2:188513706-188513707 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs559792688 | chr2:188513740-188513741 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs527331270 | chr2:188513774-188513775 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs16829180 | chr2:188513786-188513787 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs114986569 | chr2:188513850-188513851 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs532035250 | chr2:188513851-188513852 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs144189282 | chr2:188513875-188513876 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs571825932 | chr2:188513878-188513879 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs374528875 | chr2:188513911-188513912 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Breast cancer | 17603634 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Ependymoma | 16718352 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Melanoma | 18172304 | CNVD |
Cancer | 16751803 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Breast cancer | 16272173 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Cancer | 21637783 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Liposarcoma | 21253554 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Embryonal rhabdomyosarcoma | 16790082 | CNVD |
Autism | 16446308 | CNVD |
Autism | 19401682 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Lung cancer | 18438408 | CNVD |
Glioblastoma | 21080181 | CNVD |
Prostate cancer | 18632612 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Facial dysmorphism | 20548289 | CNVD |
Mental retardation | 20548289 | CNVD |
Biliary cancer | 20360734 | CNVD |
Breast cancer | 20360734 | CNVD |
Coronary artery disease | 20360734 | CNVD |
Crohn''s disease | 20360734 | CNVD |
Hypertension | 20360734 | CNVD |
Rheumatoid arthritis | 20360734 | CNVD |
Type 1 diabetes | 20360734 | CNVD |
Type 2 diabetes | 20360734 | CNVD |
Breast cancer | 21364760 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Cancer | 21183584 | CNVD |
Sudden cardiac death | 19188705 | CNVD |
Autism | 19329560 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Intellectual disability | 22102821 | CNVD |
Tetralogy of Fallot | 22912587 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr2:188500200-188519400 | Weak transcription | ES-WA7 Cell Line | embryonic stem cell |
2 | chr2:188503000-188522000 | Weak transcription | H9 Cell Line | embryonic stem cell |
3 | chr2:188503000-188525800 | Weak transcription | ES-UCSF4 Cell Line | embryonic stem cell |
4 | chr2:188506000-188514600 | Weak transcription | HUES48 Cell Line | embryonic stem cell |
5 | chr2:188506200-188515400 | Weak transcription | HUES6 Cell Line | embryonic stem cell |
6 | chr2:188509600-188519400 | Weak transcription | ES-I3 Cell Line | embryonic stem cell |
7 | chr2:188513200-188522000 | Weak transcription | iPS-20b Cell Line | embryonic stem cell |
8 | chr2:188513800-188526400 | Weak transcription | iPS DF 6.9 Cell Line | embryonic stem cell |
9 | chr2:188514400-188519200 | Weak transcription | iPS-18 Cell Line | embryonic stem cell |
10 | chr2:188514600-188516200 | Strong transcription | HUES48 Cell Line | embryonic stem cell |
11 | chr2:188514800-188521200 | Weak transcription | HUES64 Cell Line | embryonic stem cell |
12 | chr2:188515400-188517800 | Strong transcription | HUES6 Cell Line | embryonic stem cell |
13 | chr2:188516200-188519400 | Weak transcription | HUES48 Cell Line | embryonic stem cell |
14 | chr2:188517800-188519400 | Weak transcription | HUES6 Cell Line | embryonic stem cell |